{"id":9678,"date":"2022-09-28T14:45:45","date_gmt":"2022-09-28T12:45:45","guid":{"rendered":"https:\/\/biopmed.eu\/?p=9182"},"modified":"2023-02-27T14:32:58","modified_gmt":"2023-02-27T13:32:58","slug":"eurostars-3-cod-3-innovative-smes-2022","status":"publish","type":"post","link":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/","title":{"rendered":"Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022"},"content":{"rendered":"\r\n<p>Il Ministero dello Sviluppo economico ha pubblicato il\u00a0<a href=\"https:\/\/eu-central-1.protection.sophos.com\/?d=outlook.com&amp;u=aHR0cHM6Ly9ldXIwNS5zYWZlbGlua3MucHJvdGVjdGlvbi5vdXRsb29rLmNvbS8_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&amp;i=NjI0YmY0YjBkYjU3MWUxMWJhNzliYTli&amp;t=SVZJT245WU1XUXI0bnEvWFViODlmdkFRNkdJVWZxM1B1VHRGeDJIM1M4VT0=&amp;h=869076fac9034824ae5bbead24ae8083\" target=\"_blank\" rel=\"noreferrer noopener\">decreto ministeriale 19 settembre 2022<\/a>&#8211; <strong>Innovative SMEs 2022<\/strong>.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\">Di cosa si tratta?<\/h3>\r\n\r\n\r\n\r\n<p>L\u2019iniziativa europea Innovative SMEs \u2013 facente parte dell\u2019Horizon EU \u2013 coinvolge 37 paesi europei ed extraeuropei e ha lo scopo di <strong>supportare le PMI innovative, per accrescerne la loro capacit\u00e0 di ricerca e innovazione e la loro produttivit\u00e0, nonch\u00e9 di integrarsi nelle catene globali del valore e in nuovi mercati<\/strong>. Nell\u2019ambito dell\u2019iniziativa, \u00e8 stato lanciato il bando \u201cEurostars 3 CoD 3\u201d ed il MISE, tramite il decreto, <strong>ha destinato 7 milioni di euro per sostenere le progettualit\u00e0 delle imprese italiane selezionate, a valere sulle risorse del PNRR, anche al fine di raggiungere i target della M4C2-2<\/strong>.<\/p>\r\n\r\n\r\n\r\n<p>In particolare, il provvedimento prevede che siano destinati il 40% dei finanziamenti a beneficiari delle Regioni del Mezzogiorno.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\">Chi pu\u00f2 accedere alle agevolazioni?<\/h3>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>Le PMI e le start-up innovative<\/li>\r\n<li>Gli organismi di ricerca<\/li>\r\n<li>Le grandi imprese, purch\u00e9 sia presente almeno una PMI o una start-up<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>In caso di coinvolgimento di pi\u00f9 soggetti si deve fare ricorso ai contratti di rete. Inoltre, sono descritte le caratteristiche che le imprese e gli organismi di ricerca devono avere per accedere ai finanziamenti.<\/p>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><strong>Caratteristiche dei progetti<\/strong>\u00a0<\/h3>\r\n\r\n\r\n\r\n<p>I progetti ammissibili alle agevolazioni devono prevedere la realizzazione di attivit\u00e0 di ricerca industriale e di preponderante sviluppo sperimentale, finalizzate alla realizzazione di nuovi prodotti, processi o servizi che possano essere rapidamente commercializzati in Europa e\/o nei mercati globali, in relazione agli obiettivi specifici previsti dal bando \u201cEurostars 3 CoD 3\u201d nell&#8217;ambito dell\u2019iniziativa europea Innovative SMEs e pubblicato sul sito\u00a0<a href=\"https:\/\/eu-central-1.protection.sophos.com\/?d=outlook.com&amp;u=aHR0cHM6Ly9ldXIwNS5zYWZlbGlua3MucHJvdGVjdGlvbi5vdXRsb29rLmNvbS8_dXJsPWh0dHBzJTNBJTJGJTJGd3d3LmV1cmVrYW5ldHdvcmsub3JnJTJGJmRhdGE9MDUlN0MwMSU3QyU3QzEyNmE3YThmNjNmMjQ2MjE1MDMzMDhkYTliMWM4ODYyJTdDMzA3YTIxNWQwNTNlNDhiMWE3M2UzMGYwOGYwOGNiMGIlN0MwJTdDMCU3QzYzNzk5Mjg0NDA4NTMxMTUxNCU3Q1Vua25vd24lN0NUV0ZwYkdac2IzZDhleUpXSWpvaU1DNHdMakF3TURBaUxDSlFJam9pVjJsdU16SWlMQ0pCVGlJNklrMWhhV3dpTENKWFZDSTZNbjAlM0QlN0MzMDAwJTdDJTdDJTdDJnNkYXRhPWRxN0wwVEtocHdJcXBUek5sNldZQTlzNCUyQkF3RlRWRFRXUm1tb1dDUmVPQSUzRCZyZXNlcnZlZD0w&amp;i=NjI0YmY0YjBkYjU3MWUxMWJhNzliYTli&amp;t=anErRG1menp0TkRUNnFuVnk2NnhOYW5yaUxnKzhZOXZTQWZ4M0FNUDRvVT0=&amp;h=869076fac9034824ae5bbead24ae8083\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.eurekanetwork.org<\/a>. Ai fini dell\u2019ammissibilit\u00e0 alle agevolazioni, i progetti di ricerca e sviluppo devono avere le seguenti caratteristiche:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>interessare qualsiasi area tecnologica, purch\u00e9 focalizzata esclusivamente su applicazioni civili;<\/li>\r\n<li>coinvolgere nell\u2019ambito del progetto transnazionale le PMI e le start-up nell\u2019ambito di una o pi\u00f9 delle proprie unit\u00e0 locali ubicate nel territorio nazionale;<\/li>\r\n<li>coinvolgere almeno una PMI italiana, che esponga almeno il 50% dei costi della partecipazione italiana;<\/li>\r\n<li>essere avviati successivamente alla data di presentazione della domanda di agevolazioni e, comunque, pena la revoca, non oltre 3 mesi dalla data del decreto di concessione;<\/li>\r\n<li>avere una durata massima di 36 mesi;<\/li>\r\n<li>contribuire al conseguimento degli obiettivi climatici (almeno il 60% dell\u2019investimento) e alla transizione digitale (almeno il 40% dell\u2019investimento);<\/li>\r\n<li>garantire l\u2019assenza del doppio finanziamento.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<h3 class=\"wp-block-heading\"><strong>Apertura sportello agevolativo\u00a0<\/strong><\/h3>\r\n\r\n\r\n\r\n<p>I termini e le modalit\u00e0 per la presentazione delle domande di agevolazione saranno definiti dal Ministero con successivo provvedimento direttoriale congiunto della Direzione generale per le tecnologie delle comunicazioni e la sicurezza informatica (DGTCSI) e della Direzione generale per gli incentivi alle imprese (DGIAI).<\/p>\r\n\r\n\r\n\r\n<p>Il decreto sar\u00e0 trasmesso ai competenti organi di controllo e successivamente pubblicato nella Gazzetta Ufficiale.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Il Ministero dello Sviluppo economico ha pubblicato il\u00a0decreto ministeriale 19 settembre 2022&#8211; Innovative SMEs 2022. Di cosa si tratta? L\u2019iniziativa europea Innovative SMEs \u2013 facente parte dell\u2019Horizon EU \u2013 coinvolge &hellip; <a href=\"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","cybocfi_hide_featured_image":"","footnotes":""},"categories":[60],"tags":[],"class_list":["post-9678","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed\" \/>\n<meta property=\"og:description\" content=\"Il Ministero dello Sviluppo economico ha pubblicato il\u00a0decreto ministeriale 19 settembre 2022&#8211; Innovative SMEs 2022. Di cosa si tratta? L\u2019iniziativa europea Innovative SMEs \u2013 facente parte dell\u2019Horizon EU \u2013 coinvolge &hellip; Continue reading Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"bioPmed\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-28T12:45:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-27T13:32:58+00:00\" \/>\n<meta name=\"author\" content=\"bioPmed\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bioPmed\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/\"},\"author\":{\"name\":\"bioPmed\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/#\\\/schema\\\/person\\\/cbe3197b8d8d2ed4e8a1b798451eac88\"},\"headline\":\"Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022\",\"datePublished\":\"2022-09-28T12:45:45+00:00\",\"dateModified\":\"2023-02-27T13:32:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/\"},\"wordCount\":447,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/\",\"url\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/\",\"name\":\"Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/#website\"},\"datePublished\":\"2022-09-28T12:45:45+00:00\",\"dateModified\":\"2023-02-27T13:32:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/#\\\/schema\\\/person\\\/cbe3197b8d8d2ed4e8a1b798451eac88\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/eurostars-3-cod-3-innovative-smes-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/\",\"name\":\"bioPmed\",\"description\":\"Piemonte Innovation Cluster\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/#\\\/schema\\\/person\\\/cbe3197b8d8d2ed4e8a1b798451eac88\",\"name\":\"bioPmed\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g\",\"caption\":\"bioPmed\"},\"sameAs\":[\"https:\\\/\\\/biopmed.eu\"],\"url\":\"https:\\\/\\\/biopmed.eu\\\/en\\\/author\\\/bpmadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/","og_locale":"en_US","og_type":"article","og_title":"Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed","og_description":"Il Ministero dello Sviluppo economico ha pubblicato il\u00a0decreto ministeriale 19 settembre 2022&#8211; Innovative SMEs 2022. Di cosa si tratta? L\u2019iniziativa europea Innovative SMEs \u2013 facente parte dell\u2019Horizon EU \u2013 coinvolge &hellip; Continue reading Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022","og_url":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/","og_site_name":"bioPmed","article_published_time":"2022-09-28T12:45:45+00:00","article_modified_time":"2023-02-27T13:32:58+00:00","author":"bioPmed","twitter_card":"summary_large_image","twitter_misc":{"Written by":"bioPmed","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/#article","isPartOf":{"@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/"},"author":{"name":"bioPmed","@id":"https:\/\/biopmed.eu\/en\/#\/schema\/person\/cbe3197b8d8d2ed4e8a1b798451eac88"},"headline":"Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022","datePublished":"2022-09-28T12:45:45+00:00","dateModified":"2023-02-27T13:32:58+00:00","mainEntityOfPage":{"@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/"},"wordCount":447,"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/","url":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/","name":"Eurostars 3 CoD 3 - Innovative SMEs 2022 - bioPmed","isPartOf":{"@id":"https:\/\/biopmed.eu\/en\/#website"},"datePublished":"2022-09-28T12:45:45+00:00","dateModified":"2023-02-27T13:32:58+00:00","author":{"@id":"https:\/\/biopmed.eu\/en\/#\/schema\/person\/cbe3197b8d8d2ed4e8a1b798451eac88"},"breadcrumb":{"@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/biopmed.eu\/en\/eurostars-3-cod-3-innovative-smes-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/biopmed.eu\/en\/"},{"@type":"ListItem","position":2,"name":"Eurostars 3 CoD 3 &#8211; Innovative SMEs 2022"}]},{"@type":"WebSite","@id":"https:\/\/biopmed.eu\/en\/#website","url":"https:\/\/biopmed.eu\/en\/","name":"bioPmed","description":"Piemonte Innovation Cluster","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biopmed.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/biopmed.eu\/en\/#\/schema\/person\/cbe3197b8d8d2ed4e8a1b798451eac88","name":"bioPmed","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d8f2333a318acc02c0da27da0be05b06ae268e8cd1e10041de92795311db93c0?s=96&d=mm&r=g","caption":"bioPmed"},"sameAs":["https:\/\/biopmed.eu"],"url":"https:\/\/biopmed.eu\/en\/author\/bpmadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/posts\/9678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/comments?post=9678"}],"version-history":[{"count":2,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/posts\/9678\/revisions"}],"predecessor-version":[{"id":9901,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/posts\/9678\/revisions\/9901"}],"wp:attachment":[{"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/media?parent=9678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/categories?post=9678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biopmed.eu\/en\/wp-json\/wp\/v2\/tags?post=9678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}